$1.21
0.00% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
IL0011050551
Symbol
EVGN

Evogene Ltd Stock price

$1.21
-0.16 11.68% 1M
-0.28 18.60% 6M
-0.66 35.29% YTD
-2.67 68.81% 1Y
-8.89 88.02% 3Y
-10.49 89.66% 5Y
-87.49 98.64% 10Y
-25.79 95.52% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.00 0.00%
ISIN
IL0011050551
Symbol
EVGN
Industry

Key metrics

Basic
Market capitalization
$10.5m
Enterprise Value
$13.7m
Net debt
$3.1m
Cash
$9.9m
Shares outstanding
6.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.6 | 1.6
EV/Sales
2.0 | 2.1
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-3.6%
Return on Equity
1,136.1%
ROCE
-120.0%
ROIC
-104.3%
Debt/Equity
-3.6
Financials (TTM | estimate)
Revenue
$6.8m | $6.6m
EBITDA
$-20.0m | $-14.7m
EBIT
$-22.4m | $-19.1m
Net Income
$-15.2m | $-15.0m
Free Cash Flow
$-21.4m
Growth (TTM | estimate)
Revenue
-26.3% | -22.6%
EBITDA
3.0% | 23.3%
EBIT
3.6% | 11.9%
Net Income
29.1% | 8.8%
Free Cash Flow
-4.6%
Margin (TTM | estimate)
Gross
41.1%
EBITDA
-296.1% | -223.7%
EBIT
-331.7%
Net
-224.8% | -228.1%
Free Cash Flow
-316.0%
More
EPS
$-2.2
FCF per Share
$-3.2
Short interest
1.7%
Employees
117
Rev per Employee
$70.0k
Show more

Is Evogene Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Evogene Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Evogene Ltd forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Evogene Ltd forecast:

Buy
88%
Hold
13%

Financial data from Evogene Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
6.77 6.77
26% 26%
100%
- Direct Costs 3.99 3.99
138% 138%
59%
2.78 2.78
63% 63%
41%
- Selling and Administrative Expenses 10 10
1% 1%
150%
- Research and Development Expense 15 15
28% 28%
222%
-20 -20
3% 3%
-296%
- Depreciation and Amortization 2.41 2.41
9% 9%
36%
EBIT (Operating Income) EBIT -22 -22
4% 4%
-331%
Net Profit -15 -15
29% 29%
-225%

In millions USD.

Don't miss a Thing! We will send you all news about Evogene Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evogene Ltd Stock News

Neutral
PRNewsWire
about 3 hours ago
A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia   and Gout. REHOVOT, Israel , Aug. 12, 2025 /PRNewswire/ -- Evogene Ltd.
Neutral
PRNewsWire
14 days ago
Zoom conference call scheduled for August 19, 2025, 9:00 AM ET REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday , August 19 , 2025.
Neutral
PRNewsWire
about one month ago
REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd.  (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of t...
More Evogene Ltd News

Company Profile

Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities. The company was founded by Amir Barzilay and Hagai Karchi in 2002 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Ofer Haviv
Employees 117
Founded 1999
Website evogene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today